Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications
Pharmacological Research · 2026-09 · 231 · 108346
DOI: 10.1016/j.phrs.2026.108346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmacological Research, 2026-09. Verfasst von Qianyu Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; School of Stom…. Hauptthemen laut MEDLINE: Acetyl Coenzyme A, Bone and Bones, Bone Diseases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 182 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Acetyl-CoA is a central metabolite that links energy status to transcriptional regulation through protein acetylation, yet its functions in skeletal biology depend strongly on subcellular compartmentalization. Because acetyl-CoA does not freely traverse biological membranes, its mitochondrial, cytosolic, and nuclear pools are maintained through compartment-specific synthesis and exchange routes, including the citrate-SLC25A1-ACLY axis, acetylcarnitine/carnitine cycling, acetate-dependent ACSS2 activity, and local nuclear enzyme activity. This review synthesizes current evidence that three conserved modules, including glycolytic/PDC-driven mitochondrial production, CIC/ACLY-mediated citrate export, and HAT-dependent acetylation, connect carbon flux with skeletal cell fate. However, lineage-specific outcomes are shaped by local acetyl-CoA availability, acetyltransferase context, and the transcription-factor landscape, including RUNX2 (osteogenesis), SOX9 (chondrogenesis) and NFATc1 (osteoclastogenesis). Critically, compartmentalized acetyl-CoA dysregulation can contribute to different pathological states: excess acetyl-CoA supply is linked to ACLY/FAO-driven cartilage catabolism and osteoclast resorption, whereas insufficient nucleocytosolic supply is associated with impaired regenerative programs in aged or inflamed bone. This duality argues for context-specific therapeutic strategies that either restrain excess acetyl-CoA flux or restore deficient pools. We propose that the translational bottleneck is not target identification but delivery precision, advocating for localized metabolite supplementation, cell-selective ACLY/FAO inhibitors, and spatial acetylome mapping to deconvolute cell-type-specific fluxes. Moving beyond broad HDAC/HAT modulation toward compartment-resolved strategies will be essential for translating acetyl-CoA biology into effective skeletal therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; School of Stomatology, Tongji Medical College, Huazhong University of Science and Te…
- Department of Stomatology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Electronic address: 18971566966@163.com.
Zitieren
APA
Yang, Q., Shi, R., Zhang, C., Sun, W., & Chen, G. (2026). Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications. Pharmacological Research, 231, 108346. https://doi.org/10.1016/j.phrs.2026.108346
Vancouver
Yang Q, Shi R, Zhang C, Sun W, Chen G. Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications. Pharmacological Research. 2026;231:108346. doi:10.1016/j.phrs.2026.108346
BibTeX
@article{Yang2026,
author = {Yang, Qianyu and Shi, Runlin and Zhang, Chenyang and Sun, Wei and Chen, Guangjin},
title = {Acetyl-CoA metabolism in skeletal biology and bone disorders: From mechanisms to therapeutic implications},
journal = {Pharmacological Research},
year = {2026},
volume = {231},
pages = {108346},
doi = {10.1016/j.phrs.2026.108346}
}
EUVIMED